Skip to content

Move For Surgery - A Novel Preconditioning Program

Move For Surgery - A Novel Preconditioning Program to Optimize Health Before Thoracic Surgery: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03689634
Acronym
MFS
Enrollment
102
Registered
2018-09-28
Start date
2018-10-15
Completion date
2022-06-01
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Nonsmall Cell

Brief summary

Lung cancer is the leading cause of cancer death in Canada. Most patients with this cancer will undergo treatment with major chest surgery that is associated with serious complications. As many as 50% of patients will suffer respiratory complications after surgery, keeping them in the hospital for extended periods of time. These long hospitalizations have a dramatic negative effect on the lives of those people, in addition to a large cost burden on our healthcare system. Traditionally, patients who suffer from complications are treated with rehabilitation AFTER the complications have occurred. But what if complications can be prevented BEFORE they happen? Having major chest surgery imposes great stress on the human body, one that is equivalent to running a marathon. Analogous to training before completing a marathon, the investigator designed Move For Surgery (MFS), a novel preconditioning program that encourages and empowers patients to improve their health prior to surgery. The investigator aims to demonstrate that patients who train with Move For Surgery will have lower respiratory complication rates, will recover better, and will leave the hospital sooner than their counterparts.

Interventions

DEVICEMove For Surgery Preconditioning Program using a Wearable Activity Tracker (Fitbit) Intervention Group

Participants randomized to this group will be be provided with a wearable activity tracker (Fitbit) for the duration of the study and asked to reach daily step goals.

Sponsors

Hamilton Academic Health Sciences Organization
CollaboratorOTHER
St. Joseph's Healthcare Hamilton
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Clinical stage I, II, or IIIa non-small cell lung cancer (NSCLC) * Candidates for thoracic surgery, as determined by the operating surgeon

Exclusion criteria

* Clinical stage IIIb or IV NSCLC * Patients with affected mobility (wheelchair, walker) * Patients who use oxygen at home

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome of the comparative trial will be length of stay (LOS) in hospital after surgery, which will also be used to measure speed of recovery from surgery and postoperative complications.24 monthsLOS is a good surrogate measure for the speed of recovery from surgery (patients who recover faster leave hospital earlier) and postoperative complications (patients who do not suffer complications leave the hospital earlier).

Secondary

MeasureTime frameDescription
Secondary outcome will include differences in the 36-Item Short Form Health Survey (SF-36) scores before and after the intervention.24 monthsThe quality of life as reported by patients will be compared.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026